Search

Author/Creator Horvath, Noemi

2. A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. Issue 5 (21st February 2014)

Authors:
Hertzberg, Mark; Matthews, Jane Palfrey; Stone, Janey Malka; Dubosq, Ming‐Celine; Grigg, Andrew; Ellis, David; Benson, Warwick; Browett, Peter; Horvath, Noemi; Januszewicz, Henry; Abdi, Ehtesham; Green, Michael; Bonaventura, Anthony; Marlton, Paula; Cannell, Paul; Wolf, Max
Journal:
American journal of hematology
Issue:
Volume 89:Issue 5(2014:May)
Page Start:
536
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

Authors:
Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar...
Journal:
Lancet
Issue:
Volume 9:Issue 6(2022)
Page Start:
e403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Issue 8 (August 2017)

Authors:
Lee, Oi Lin; Horvath, Noemi; Lee, Cindy; Joshua, Doug; Ho, Joy; Szer, Jeff; Quach, Hang; Spencer, Andrew; Harrison, Simon; Mollee, Peter; Roberts, Andrew W.; Talaulikar, Dipti; Brown, Ross; Augustson, Bradley; Ling, Silvia; Jaksic, Wilfrid; Gibson, John; Kalff, Anna; Johnston, Anna; Kalro, Akash
Journal:
Internal medicine journal
Issue:
Volume 47:Issue 8(2017)
Page Start:
938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry‐based proteomics in an Australian cohort. Issue 1 (20th January 2022)

Authors:
Withers, Barbara; McCaughan, Georgia; Hayward, Christopher; Kotlyar, Eugene; Jabbour, Andrew; Rainer, Stephen; De Angelis, Enzo; Horvath, Noemi; Milliken, Sam; Dogan, Ahmet; MacDonald, Peter; Moore, John
Journal:
Internal medicine journal
Issue:
Volume 52:Issue 1(2022)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. Issue 1 (December 2016)

Authors:
Bergin, Krystal; Moore, Elizabeth; McQuilten, Zoe; Wood, Erica; Augustson, Bradley; Blacklock, Hilary; Ho, Joy; Horvath, Noemi; King, Tracy; McNeil, John; Mollee, Peter; Quach, Hang; Reid, Christopher; Rosengarten, Brian; Walker, Patricia; Spencer, Andrew
Journal:
BMC medical research methodology
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma. Issue 13 (18th May 2016)

Authors:
Orlowski, Robert Z.; Nagler, Arnon; Sonneveld, Pieter; Bladé, Joan; Hajek, Roman; Spencer, Andrew; Robak, Tadeusz; Dmoszynska, Anna; Horvath, Noemi; Spicka, Ivan; Sutherland, Heather J.; Suvorov, Alexander N.; Xiu, Liang; Cakana, Andrew; Parekh, Trilok; San‐Miguel, Jesús F.
Journal:
Cancer
Issue:
Volume 122:Issue 13(2016)
Page Start:
2050
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia. Issue 10 (18th October 2021)

Authors:
Creeper, Katherine; Augustson, Bradley; Kusel, Kieran; Fulham, Michael J.; Ho, Joy; Quach, Hang; Mollee, Peter; Weber, Nicholas; Talaulikar, Dipti; Johnston, Anna; Murphy, Nick; Joshua, Douglas; Ward, Christopher; Ling, Silvia; Gibson, John; Szer, Jeff; Harrison, Simon; Zannettino, Andrew; Jaksic...
Journal:
Internal medicine journal
Issue:
Volume 51:Issue 10(2021)
Page Start:
1707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Issue 9 (29th July 2019)

Authors:
Horvath, Noemi; Spencer, Andrew; Kenealy, Melita; Joshua, Douglas; Campbell, Philip J; Lee, Je-Jung; Hou, Jian; Qiu, Lugui; Kalff, Anna; Khong, Tiffany; Londhe, Anil; Siggins, Sarah; van Kooten Losio, Maximiliano; Eisbacher, Michael; Prince, H. Miles
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 9(2019)
Page Start:
2122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Issue 1 (January 2017)

Authors:
Talaulikar, Dipti; Tam, Constantine S.; Joshua, Douglas; Ho, Joy Phoebe; Szer, Jeff; Quach, Hang; Spencer, Andrew; Harrison, Simon; Mollee, Peter; Roberts, Andrew W.; Horvath, Noemi; Lee, Cindy; Zannettino, Andrew; Brown, Ross; Augustson, Bradley; Jaksic, Wilfrid; Gibson, John; Kalff, Anna; Johns...
Journal:
Internal medicine journal
Issue:
Volume 47:Issue 1(2017)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗